Eden Research plc (EDEN) Ordinary 1p

Sell:3.70pBuy:4.00p0.10p (2.67%)

Prices delayed by at least 15 minutes
Sell:3.70p
Buy:4.00p
Change:0.10p (2.67%)
Prices delayed by at least 15 minutes
Sell:3.70p
Buy:4.00p
Change:0.10p (2.67%)
Prices delayed by at least 15 minutes

Company Information

About this company

Eden Research plc is a United Kingdom-based company, which is focused on biopesticides for sustainable agriculture. The Company develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products are formulated with terpene active ingredients, based on natural plant defense metabolites. Its product portfolio includes Mevalone and Cedroz. Mevalone is a foliar biofungicide, which targets a key disease affecting grapes and other high-value fruit and vegetable crops. Cedroz is a bionematicide that targets free-living nematodes, which are parasitic worms that affect a range of high-value fruit and vegetable crops globally. The Company's Sustaine encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease of use.

Key people

Sean M Smith
Chief Executive Officer, Executive Director
Alex J. Abrey
Chief Financial Officer, Company Secretary, Executive Director
Lykele Van Der Broek
Non-Executive Independent Chairman of the Board
Derek Ian Mcallan
Non-Executive Director
Robin James Scot Cridland
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    EDEN
  • Location
    United Kingdom
  • Sector
    Basic Materials
  • Industry
    Chemical Manufacturing
  • ISIN
    GB0001646941
  • Market cap
    £20.53m
  • Employees
    19
  • Shares in issue
    533.35m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.